N ‐acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double‐blind, placebo‐controlled trial

Lai, Zhi‐Wei, Hanczko, Robert, Bonilla, Eduardo, Caza, Tiffany N., Clair, Brandon, Bartos, Adam, Miklossy, Gabriella, Jimah, John, Doherty, Edward, Tily, Hajra, Francis, Lisa, Garcia, Ricardo, Dawood, Maha, Yu, Jianghong, Ramos, Irene, Coman, Ioana, Faraone, Stephen V., Phillips, Paul E., Perl, Andras·2012·Arthritis & Rheumatism
DOI 10.1002/art.34502

Cited by (427)

Items 301–400 of 427

  1. T cell involvement in antiphospholipid syndrome
    Maria G. Tektonidou, Nikolaos I. Vlachogiannis, Petros Paul Sfikakis · 2024 · Clinical Immunology
  2. A 50‐Year‐Old Woman With Cowden Syndrome and Joint Pains
    Vinay Sagar, Jeffrey R. Bond, VAIDEHI R. CHOWDHARY · 2015 · Arthritis Care & Research
  3. Improved strategies for designing lupus trials with targeted therapies: learning from 65 years of experience
    Daniel J. Wallace · 2016 · Lupus
  4. Altered Tregs and oxidative stress in pregnancy associated lupus
    Naveet Pannu, Rashmi Singh, S.K. Sharma, Seema Chopra, Archana Bhatnagar · 2019 · Revista Brasileira de Reumatologia
  5. Metabolic traits of T cells and the implications in autoimmune diseases
    Yi Zhou, YX Zhou, Qing Zhu, Weinan Guo, Chunying Li · 2026 · Autoimmunity Reviews
  6. Immune cell signaling in autoimmune diseases
    George C. Tsokos, Noel R. Rose · 2017 · Clinical Immunology
  7. Metabolic Modulators in Cardiovascular Complications of Systemic Lupus Erythematosus
    Sofía Miñano, Cristina González‐Correa, Javier Moleón, Juan Duarte · 2023 · Biomedicines
  8. T Cells as Treatment Targets in Systemic Lupus Erythematosus
    Christine Konya · 2013 · Rheumatology Current Research
  9. Personalized therapy design for systemic lupus erythematosus based on the analysis of protein-protein interaction networks
    Elizabeth J. Brant, Edward A. Rietman, Giannoula Lakka Klement, Marco Cavaglià, Jack A. Tuszyński · 2020 · PLoS ONE
  10. Aberrant glucose metabolism drives dysfunction of CD4+ T cells in systemic lupus erythematosus and disease flares
    Jin Lu, Meng Ding, Shaoxin Cui, Lin Yang, Jinwen Zhao, Jingjing He, Xiaoping Wang, Fei Chang, Xue Liu, Qun Wang et al. · 2025 · Central European Journal of Immunology
  11. Novel Treatments in Lupus
    Vasileios C. Kyttaris · 2017 · Current Rheumatology Reports
  12. Granulocytes: Neutrophils, Basophils, Eosinophils
    Xavier Bosch, Manuel Ramos‐Casals · 2019 · Elsevier eBooks
  13. T-cell biology, tolerance, and regulation
    Antonio La Cava · 2021 · Elsevier eBooks
  14. Oral high-dose acetylcysteine: Effective against the Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)?
    Guangbin Chen, Hongzhou Lu · 2022 · Drug Discoveries & Therapeutics
  15. MDSCs participate in the pathogenesis of diffuse pulmonary hemorrhage in murine lupus through mTOR-FoxO1 signaling
    Liping Tan, Guo‐Ping Shi, Junyu Zhao, Xiaoyu Xia, Dan Li, Saiwen Wang, Jun Liang, Yayi Hou, Huan Dou · 2022 · Biochemistry and Biophysics Reports
  16. Constitutional Symptoms and Fatigue in Systemic Lupus Erythematosus
    S. S. Shaharir, Caroline Gordon, John A. Reynolds · 2016 · Elsevier eBooks
  17. Glutathione an Effective Adjuvant Therapy for Acute Respiratory Distress Syndrome Associated with COVID-19 Infection
    Bhupesh Dewan, Siddheshwar Shinde · 2022 · Journal of Advances in Medicine and Medical Research
  18. Exploring the shared mechanism of fatigue between systemic lupus erythematosus and myalgic encephalomyelitis/chronic fatigue syndrome: monocytic dysregulation and drug repurposing
    Daisi Zheng, Xiaolong Li, Peicheng Wang, Qingmiao Zhu, Zhiyan Huang, Ting Zhao · 2025 · Frontiers in Immunology
  19. Efficacy of N-Acetylcysteine as an Adjuvant Therapy for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Tingting He, Kehui Ren, Xiang Li, Huan Yao, Yucheng Huang, Yongxiang Gao · 2024 · British Journal of Hospital Medicine
  20. Moderne Konzepte der Nanobiotechnologie für mRNA‐Abgabesysteme
    Yue Wang, Chengzhong Yu · 2020 · Angewandte Chemie
  21. Investigating Fatigue and Exercise Intolerance in a University Immunology Clinic
    Julian L. Ambrus · 2020 · Archives of Rheumatology & Arthritis Research
  22. Evaluation of thiol/disulfide hemostasis and serum Ischemia modified albumin as oxidative stress biomarkers in systemic lupus erythematosus patients: Relationship with major organ involvement and disease activity
    Selime Ermurat, Elif Güler Kazancı, Dilara TOKA, Koray Ayar, Funda Karakoyunlu Eren, Salim Neşeli̇oğlu · 2022 · Lupus
  23. Editorial: LINEing Up to Boost Interferon Production: Activation of Endogenous Retroviral DNA in Autoimmunity
    András Perl · 2016 · Arthritis & Rheumatology
  24. Editorial: Podocytes as Active Participants in Lupus Nephritis
    Ian R. Rifkin, Ramon G. B. Bonegio · 2017 · Arthritis & Rheumatology
  25. Editorial: New biomarkers for the diagnosis and treatment of systemic lupus erythematosus
    András Perl, Nancy Agmon‐Levin, José Carlos Crispín, Trine N. Jørgensen · 2022 · Frontiers in Immunology
  26. GNS561 (ezurpimtrostat), a small basic lipophilic molecule, prevents lupus phenotype in a pristane‐induced lupus mouse model
    Eya Toumi, Eloïne Bestion, Muriel Militello, Hubert Lépidi, Anne Plauzolles, Nathalie Bardin, Daniel Bertin, Laurent Chiche, Jean‐Louis Mège, Philippe Halfon et al. · 2025 · British Journal of Pharmacology
  27. Targeting the ROS-ferroptosis axis: A clinical perspective on oxidative stress management in systemic lupus erythematosus
    Xiaoyan Xu, Wenfeng Gao, Lei Pang, Yiming Chen, Shuijing Liang, Xiaodong Wang · 2025 · The American Journal of the Medical Sciences
  28. Hepatic control of immunometabolism: implications for the pathogenesis, diagnosis and treatment of rheumatic diseases
    András Perl, Katalin Banki · 2026 · Nature Reviews Rheumatology
  29. Metabolic control of pathogenesis in autoimmune diseases
    András Perl, Laurence M Morel · 2024 · Elsevier eBooks
  30. N-Acetylcysteine Inhibits Coxsackievirus B3 Replication by Downregulating Eukaryotic Translation Elongation Factor 1 Alpha 1
    Yao Wang, Tian Luan, Lixin Wang, Danxiang Feng, Yanyan Dong, S.W. Li, Hong Yang, Yang Chen, Yanru Fei, Lexun Lin et al. · 2024 · Viruses
  31. Ferroptosis in immune chaos: Unraveling its impact on disease and therapeutic potential
    Thanyaporn Direksunthorn, Abdulrahman T. Ahmed, Nakaraj Pluetrattanabha, Subasini Uthirapathy, Suhas Ballal, Abhayveer Singh, Hussein Riyadh Abdul Kareem Al‐Hetty, Anita Devi, Girish Chandra Sharma, Alexei Valerievich Yumashev · 2025 · Journal of Physiology and Biochemistry
  32. Anti-Tumoral Treatment with Thioredoxin Reductase 1 Inhibitor Auranofin Fosters Regulatory T Cell and B16F10 Expansion in Mice
    Michael Yi Bonner, Tamás Vancsik, Ana Coelho, Pierre Sabatier, Christian Michel Beusch, Kejsi Zeqiraj, Carolin Svensson, Roman A. Zubarev, Elias S.J. Arnér, Rikard Holmdahl · 2025 · Antioxidants
  33. T Lymphocyte Metabolic Features and Techniques to Modulate Them
    Власова Виолетта Викторовна, Шмагель Константин Владимирович · 2023 · Biochemistry (Moscow)
  34. Crosstalk Between Oxidative Stress, Autophagy and Cell Death — Pathogenesis of Autoimmune Disease
    Dilip Shah, Dheeraj Mohania, Nidhi Mahajan, Sangita Sah, Bishnuhari Paudyal, Swapan K. Nath · 2015 · InTech eBooks
  35. Immunometabolic disorders in the pathogenesis of systemic lupus erythematosus
    Tokarska, Kamila, Majsterek, Ireneusz, Cuchra, Magda, Woźniacka, Anna · 2019 · Advances in Dermatology and Allergology
  36. The metabolic landscape of connective tissue diseases: Applications and discoveries in metabolomics research
    Yinlan Wu, Daihua Deng, Yanhong Li, Sijun Zhang, Tong Wu, Deying Huang, Lu Cheng, Yi Liu, Chunyu Tan, Yubin Luo · 2025 · Autoimmunity Reviews
  37. Targeting mTOR in Systemic Lupus Erythematosus: From Immune Cell Dysfunction to Clinical Translation
    Xiaojing Jiang, Lu Sun, J M Ji, Chaoran Zhao, Yan Wang, Haitao Zhang, Qi Wu, Qinyi Su, Fang Li, Shengxiao Zhang et al. · 2026 · Journal of Inflammation Research
  38. Effects of Metabolic Dysregulation on Macrophage Polarization in Rheumatoid Arthritis
    Xinyue Zhang, Xiaoyue Deng, Shixiong Wei, Mengtao Li, Xiaofeng Zeng · 2026 · Arthritis & Rheumatology
  39. Extract from Ascaris suum and N‐acetyl‐L‐cysteine induces an immunosuppressant effect in model of autoimmune hepatitis
    Roeckson Carlos Peixoto Silva, Raul Penaforte Correia da Silva, Fabrício Oliveira Souto, Virgínia Maria Barros de Lorena, André de Lima Aires, Vláudia Maria Assis Costa, Mônica Camelo Pessoa de Azevedo Albuquerque, Valdênia Maria Oliveira de Souza · 2021 · Parasite Immunology
  40. UBQLN1 links proteostasis and mitochondria function to telomere maintenance in human embryonic stem cells
    Shuang Zhao, Jie Li, Songqi Duan, Chang Liu, Hua Wang, Jiangtao Lu, Nannan Zhao, Xiaoyan Sheng, Yiwei Wu, Yanjun Li et al. · 2024 · Stem Cell Research & Therapy
  41. Mitochondrial Metabolism
    Shannon Rose, Sirish C. Bennuri · 2018 · Springer eBooks
  42. The role of N-acetyl cysteine and some other clinical antidotes in the treatment of patients with COVID-19; review of the current evidence
    Shafeajafar Zoofaghari, Mohsen Forghani, Gholamali Dorooshi, Asieh Maghami‐Mehr · 2022 · Immunopathologia Persa
  43. Abnormal mTOR Signaling Pathway Activity in Autism Spectrum Disorders: Prospects of Mechanism-Based Therapy
    Ekaterina A. Trifonova, Анастасия Анатольевна Котлярова, Alex V. Kochetov · 2023 · Molecular Biology
  44. GLUTATHIONE: A POSSIBLE LINK TO AUTOPHAGY IN SYSTEMIC LUPUS ERYTHEMATOSUS
    Dilip Shah, Swapan K. Nath · 2014 · American Journal of Immunology
  45. Targeted Therapies in Systemic Lupus Erythematosus: A State-of-the Art Review
    Yashaar Chaichian · 2013 · Journal of Clinical & Cellular Immunology
  46. The metabolic regulation in immune cells and pathogenesis of systemic lupus erythematosus ∼toward new therapeutic applications∼
    Yusuke Takeshima, Yukiko Iwasaki, Tomohisa Okamura, Keishi Fujio, Kazuhiko Yamamoto · 2017 · Japanese Journal of Clinical Immunology
  47. Approaches to Autoimmune Diseases Using Epigenetic Therapy
    Christian Michael Hedrich · 2018 · Elsevier eBooks
  48. Reprint of "The interaction between environmental triggers and epigenetics in autoimmunity"
    Bruce Richardson · 2018 · Clinical Immunology
  49. Metabolic and mitochondrial dysfunction in SLE
    András Perl · 2021 · Elsevier eBooks
  50. Innovative Trials and New Opportunities in SLE
    Yashaar Chaichian, Daniel J. Wallace · 2021 · Rheumatic Disease Clinics of North America
  51. Immunometabolism
    Laurence M Morel · 2019 · Elsevier eBooks
  52. Iron metabolism and ferroptosis: druggable targets to delay the progression of lupus nephritis
    Leena Al-Hraki, Laurence M Morel, Yogesh M. Scindia · 2025 · American Journal of Physiology-Renal Physiology
  53. Transaldolase deficiency – natural disease course towards adulthood
    Viktória Bea Horváth, Konstantinos Tsiakas, Heiko Brennenstuhl, Daniela Choukair, Nicole Hammann, Moritz Niesert, Alexander Fichtner, Holger Prokisch, René Santer, Matias Wagner et al. · 2026 · Molecular Genetics and Metabolism
  54. Potential regulation of kynurenine pathway metabolism by the galantamine–memantine combination in rheumatologic diseases: A hypothesis-driven review
    Navya Mathew, Sebin George, Patricia Rejimon, Craig Orofino, Anam Shaikh, Darshanabahen Mistry, Leen Mazahreh, Alwin Jose, Hira Imran, Sandeepkumar J. Gupta et al. · 2026 · Journal of Pharmacology and Experimental Therapeutics
  55. Metabolic signatures in systemic autoimmune diseases: A state-of-the-art overview of systemic lupus erythematosus, primary Sjögren's syndrome, and systemic sclerosis
    Artur Jędreas, Sylwia Michorowska, Sébastien Le Jan, Amélie Servettaz, Joanna Giebułtowicz · 2026 · Autoimmunity Reviews
  56. Silica-based nanoplatforms for nucleic acid delivery: Emerging strategies and biomedical applications
    Xilong Li, Yacheng Bai, Dapeng Zhang, Yongsheng Li · 2026 · Nano Today
  57. Mitochondrial DNA in systemic lupus erythematosus: pathogenic mechanisms, clinical biomarkers, and precision therapeutic strategies
    Fugang Huang, Ke Sun, Lijia Diao, Keda Lu, Yongsheng Fan, Guanqun Xie · 2026 · Frontiers in Immunology
  58. Immunometabolic modulators alleviate vascular dysfunction in mice with systemic lupus erythematosus
    Sofía Miñano, Javier Moleón, Cristina González‐Correa, Rosario Jiménez, Manuel Gómez‐Guzmán, Natividad Martín‐Morales, Francisco O’Valle, Miguel Romero, Marta Toral, Juan Duarte · 2025 · Biochemical Pharmacology
  59. Pharmacoepigenetics of Systemic Lupus Erythematosus
    Christian Michael Hedrich · 2019 · Elsevier eBooks
  60. Insulin Resistance Associated Acne
    Raj Kubba · 2021 · Updates in clinical dermatology
  61. Twin and family studies on epigenetics of autoimmune diseases
    Zsófia Jokkel, Márton Piroska, Laszlo Szalontai, Anita Hernyes, Dávid László Tárnoki, Ádám Domonkos Tárnoki · 2021 · Elsevier eBooks
  62. Constitutional symptoms and fatigue in systemic lupus erythematosus
    Syahrul Sazliyana Shaharir, Caroline Gordon · 2020 · Elsevier eBooks
  63. T Cells
    Abel Suárez‐Fueyo, José Carlos Crispín, George C. Tsokos · 2019 · Elsevier eBooks
  64. T-Lymphocyte metabolic features and techniques to modulate them
    V. V Vlasova, Шмагель Константин Владимирович · 2023 · Biochemistry (Moscow)
  65. Systemic and Biologic Agents for Lupus Erythematosus
    Daniel J. Wallace · 2018 · Springer eBooks
  66. Thiol Containing Redox System and Blood Serum Inhibitory Properties Regarding IGM Antibodies from the Viewpoint of Pathophysiology: a Review
    Н К Родосская · 2013 · Journal of Physiology and Pharmacology Advances
  67. Metabolic control of systemic lupus erythematosus: convergence of genetic and environmental factors on mitochondrial dysfunction and mTOR reveal treatment targets in lupus
    András Perl · 2012 · Arthritis Research & Therapy
  68. T Cell Targeted Therapies in Lupus: Do They Make Sense?
    Aikaterini Thanou, Joan T. Merrill · 2015 · Current Treatment Options in Rheumatology
  69. Complementary and alternative medicine for rheumatic diseases
    Sophia Kar Yee Teng · 2016 · Hong Kong bulletin on rheumatic diseases
  70. Epigenetics of Rheumatic Diseases
    Amr H. Sawalha · 2016 · Elsevier eBooks
  71. Lupus and Lupus Overlap Diseases: Emerging Therapies
    Vasileios C. Kyttaris · 2016 · Elsevier eBooks
  72. Oxidative Stress in Systemic Lupus Erythematosus
    András Perl · 2016 · Elsevier eBooks
  73. The Clinical Use of N-Acetylcysteine in Other Medical Disorders
    Richard E. Frye · 2018 · Springer eBooks
  74. The Physiological Effects of N-Acetylcysteine in Clinical Studies
    Richard E. Frye · 2018 · Springer eBooks
  75. Complementary and Alternative Medications, Specialized and Niche Therapies
    Swamy Venuturupalli, Daniel J. Wallace · 2019 · Elsevier eBooks
  76. Tissue Damage in Lupus
    Jim C. Oates, Tamara Mann Nowling · 2019 · Elsevier eBooks
  77. New treatments of systemic lupus erythematosus
    Vasileios C. Kyttaris · 2020 · Elsevier eBooks
  78. Metabolic control of lupus pathogenesis: central role for activation of the mechanistic target of rapamycin
    András Perl · 2020 · Elsevier eBooks
  79. Influences On Monoamine Oxidase Activity In The Brain And Translation Into Major Depressive Disorder
    Sofia Raitsin · 2018 · TSpace (University of Toronto)
  80. Designed synthesis of silica based nanocarriers for mRNA delivery
    Yue Wang · 2020 · The University of Queensland
  81. Immunosuppressive therapy in SLE
    Leanna Marderian Wise, William Stohl · 2021 · Elsevier eBooks
  82. N-Acetylcysteine
    Afshin Amini, Samar Masoumi-Moghaddam, David Lawson Morris · 2016 · Springer eBooks
  83. Atemwege
    2022 · Elsevier eBooks
  84. Atemwege
    2018 · Elsevier eBooks
  85. Atemwege
    2015 · Elsevier eBooks
  86. Does the use of cysteine-rich whey protein supplements (Inmunocal®) improve the health well-being of COVID-19 patients? A qualitative study
    Betsy Cañari, Jeel Moya‐Salazar, Daniela Bussalleu, Hans Contreras‐Pulache · 2022 · Electronic Journal of General Medicine
  87. Neutrophil extracellular traps in autoimmunity, renal diseases, and transplantation
    Citlalin Vega-Roman, Zesergio Melo, Raquel Echavarría · 2023 · Elsevier eBooks
  88. Abnormal mTOR Signaling Pathway Activity in Autism Spectrum Disorders: Prospects of Mechanism-Based Therapy
    Ekaterina A. Trifonova, Анастасия Анатольевна Котлярова, Alex V. Kochetov · 2023 · Molecular Biology
  89. Nutrients and Botanical Medicines in Systemic Lupus Erythematosus
    Khara Lucius · 2023 · Integrative and Complementary Therapies
  90. Model of the systemic lupus erythematosus pathogenesis based on an autoimmune response to mitochondrial components
    Alexander V. Blagov, Alexander D. Zhuravlev, Vasily N. Sukhorukov, Mikhail Aleksandrovich Popov, Andrey V. Grechko, Alexander Nikolaevich Orekhov · 2023 · European Journal of Inflammation
  91. Approaches to autoimmune diseases using epigenetic therapy
    Christian Michael Hedrich · 2023 · Elsevier eBooks
  92. Metabolomics in Autoimmunity, Infections, and Physiological Diseases
    Suyasha Roy · 2023 · Springer eBooks
  93. Tissue damage in lupus
    Tamara K. Nowling, Jim C. Oates · 2024 · Elsevier eBooks
  94. Metabolic control of immunopathogenesis in systemic lupus erythematosus
    András Perl · 2024 · Elsevier eBooks
  95. T cells
    José Carlos Crispín, Michihito Kono, George C. Tsokos · 2024 · Elsevier eBooks
  96. Role of regulatory T cells in pathogenesis and therapeutics of systemic lupus erythematosus
    William de Jesús Ríos-Ríos, Honorio Torres Aguilar · 2024 · Elsevier eBooks
  97. Role of Metabolomics in Precision Medicine in the Context of Systemic Lupus Erythematosus and Lupus Nephritis
    Alejandra Rojo-Sánchez, Agustín Abuchaibe, Ada L. Carmona Martes, Valentina Arrieta Bravo, David Chica-Valle, Yirys Díaz-Olmos, Lisandro Pacheco-Lugo · 2024 · IntechOpen eBooks
  98. Efficacy of N-acetylcysteine for treating dryness symptoms of Sjögren's disease: randomised placebo-controlled double-blind clinical study
    Juliana D’Agostino Gennari, Giordano B. H. Deveza, Carolina Torres Ribeiro, Antônio Carlos Seguro, Nádia Emi Aikawa, Maria Heloísa Massola Shimizu, Elaine Pires Leon, Lissiane Karine Noronha Guedes, Léonard de Vinci Kanda Kupa, Clóvis A. Silva et al. · 2024 · Clinical and Experimental Rheumatology
  99. Precision mitochondrial medicine: Uncovering pathways across diverse diseases
    Lourdes Sainero‐Alcolado, Elisa Garde-Lapido, Judit Liaño-Pons, Marie Arsenian‐Henriksson · 2024 · Elsevier eBooks
  100. Pharmacoepigenetics of systemic lupus erythematosus
    Christian Michael Hedrich · 2025 · Elsevier eBooks